Table 2.

Treatment duration per TKI and median time to switch

	Imatinib n = 31	Nilotinib n = 43	Dasatinib n = 27	Ponatinib n = 5	Bosutinib n = 6	Generic imatinib n = 1
Median treatment duration, months (IQR)	14.3 (3.0–43.2)	24.0 (7.5–43.9)	22.4 (6.4–36.7)	8.4 (7.6–16.8)	4.8 (0.2–11.7)	20.3 (20.3–20.3)
N x months	812	1216	610	73.5	66	20.3
Total patient years	67	101	50.8	6.1	5.5	1.7
Median time to switch (estimate), months (95% CI)	25.4 (0.0–53.5)	69.3 (44.2–94.4)	22.2 (0.0–45.5)	4.0	N.A.	19.8

IQR interquartile range, CI confidence interval, N.A. not available